GV participated as a new investor, as genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

The Salesforce-backed online insurance platform is reportedly valued at nearly $1bn having raised funding from investors including CreditEase.

The digital contract signature platform has collected $59.2m in a round that was co-led by Tencent, with the proceeds earmarked for hiring and product development.

The rechargeable hearing aid producer has now raised more than $144m altogether, having collected about $52m in a series D round featuring Nan Fung Life Sciences.

Blue Cross of Idaho was among the investors in a series B round that took the healthcare analytics platform operator's overall funding to more than $26m

Cemex Ventures founding member and adviser Pedro Irujo left the unit in December 2018 after two years, and 13 years at its parent company.

SystemIQ, MS&AD and QBE have taken part in a round led by Invenergy's Energize Ventures unit that will support the predictive weather data provider's international growth.

Roche Venture Fund has taken part in a $38.7m round that will fund sales and commercialisation of MacuLogix's AMD diagnostics system.

Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.

Zurich brain injury antibody spinout NovaGo has extended its strategic partnership with immunotherapy company Neurimmune by securing its support in a series A round.